Uterine cancer treatments

A peptide consisting of the amino acid sequence selected from SEQ ID NO:

• 2-5, 7, 9-11, and 14-71 in the form of a salt.

A method of treating a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present on the surface a peptide consisting of the amino acid sequence selected from SEQ ID NO:

• 2-5, 7, 9-11, and 14-71,
• wherein the activated T cells bind the peptide in a complex with an MHC class I molecule on the surface of the cancer cells, and
• wherein the cancer is selected from uterine cancer, acute myelogenous leukemia, breast cancer, bile duct cancer, brain cancer, chronic lymphocytic leukemia, colorectal carcinoma, esophageal cancer, gallbladder cancer, gastric cancer, hepatocellular cancer, Merkel cell carcinoma, melanoma, non-Hodgkin lymphoma, non-small cell lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, renal cell cancer, small cell lung cancer, and urinary bladder cancer.